Publication:
Androgenetic alopecia: An evidence-based treatment update

dc.contributor.authorSupenya Varothaien_US
dc.contributor.authorWilma F. Bergfelden_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherCleveland Clinic Foundationen_US
dc.date.accessioned2018-11-09T02:55:32Z
dc.date.available2018-11-09T02:55:32Z
dc.date.issued2014-01-01en_US
dc.description.abstractBackground: Androgenetic alopecia (AGA) is one of the most common chronic problems seen by dermatologists worldwide. It is characterized by progressive hair loss, especially of scalp hair, and has distinctive patterns of loss in women versus men, but in both genders the central scalp is most severely affected. It often begins around puberty and is known to effect self-esteem and the individual's quality of life. In contrast to the high prevalence of AGA, approved therapeutic options are limited. In addition to the scarce pharmacologic treatments, there are numerous nonprescription products claimed to be effective in restoring hair in androgenetic alopecia. Objectives: The purpose of this paper is to review published medical and non-medical treatments for male and female AGA using the American College of Physicians evidence assessment methods. MEDLINE, EMBASE and Cochrane Library were searched for systematic reviews, randomized controlled trials, open studies, case reports and relevant studies of the treatment of male and female AGA. The relevant articles were classified according to grade and level of evidence. Results: The medical treatments with the best level of evidence classification for efficacy and safety for male AGA are oral finasteride and topical minoxidil solution. For female AGA, topical minoxidil solution appears to be the most effective and safe treatment. The medical treatments corresponding to the next level of evidence quality are some commonly used therapeutic non-FDA-approved options including oral and topical anti-hormonal treatments. Surgical treatment of follicular unit hair transplantation is an option in cases that have failed medical treatment although there is high variation in outcomes. Limitations: Some articles, especially those concerning traditional herbs claimed to promote hair regrowth, were published in non-English, local journals. Conclusions: An assessment of the evidence quality of current publications indicates that oral finasteride (for men only) and topical minoxidil (for men and women) are the best treatments of AGA. © 2014 Springer International Publishing.en_US
dc.identifier.citationAmerican Journal of Clinical Dermatology. Vol.15, No.3 (2014), 217-230en_US
dc.identifier.doi10.1007/s40257-014-0077-5en_US
dc.identifier.issn11791888en_US
dc.identifier.issn11750561en_US
dc.identifier.other2-s2.0-84904288077en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/34680
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84904288077&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleAndrogenetic alopecia: An evidence-based treatment updateen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84904288077&origin=inwarden_US

Files

Collections